{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-020126","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.741803+00:00","generated_at":"2026-06-05T16:00:05.294247+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"STAAR Surgical Q4 net sales up 19% to $76.3M; ICL sales +22%; FY2024 outlook $335-340M","bullets":["Q4 net sales $76.3M (+19% YoY), ICL sales $74.6M (+22%), ICL units +19%.","Q4 net income $7.8M ($0.16 EPS) vs $6.8M ($0.14 EPS); gross margin 79.6% vs 77.7%.","FY2023 net sales $322.4M (+13%), net income $21.3M ($0.43 EPS) vs $39.7M ($0.80 EPS).","Cash, cash equivalents and investments $232.4M, no debt; FY2024 net sales outlook $335-340M.","China ICL sales grew 30% in Q4; EMEA up 18%; company affirms FY2024 sales outlook."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-020126","json":"https://secwatch.observer/filing/0000950170-24-020126.json","markdown":"https://secwatch.observer/filing/0000950170-24-020126.md","text":"https://secwatch.observer/filing/0000950170-24-020126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/0000950170-24-020126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/staa-20240226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T16:00:05.294247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5993a10abab4bd967278463f2876c6d2b46d8891","claim":"STAAR SURGICAL CO updated its the quarter and year ended December 29, 2023 guidance (reaffirmed).","evidence_excerpt":"On February 26, 2024, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter and year ended December 29, 2023, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/0000950170-24-020126-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 29, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}